Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.3K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

423
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
423
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

577
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
577
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

853
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
853
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

553
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
553
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

860
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
860

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short-Term Complications and Mortality Following Open Abdominal Aortic Aneurysm Repair by a Single High-Volume Surgeon.

The Journal of surgical research·2024
Same author

Indications and outcomes of transjugular intrahepatic portosystemic shunt insertion in two regional Australian hepatology centres.

Internal medicine journal·2024
Same author

High-grade dysplasia of the cystic duct margin: how should this be managed?

BMJ case reports·2023
Same author

Brunner's gland adenoma: a robotic approach.

BMJ case reports·2023
Same author

Strategies for optimal perioperative outcomes in gastric cancer.

Journal of surgical oncology·2022
Same author

Synchronous contralateral axillary lymph node metastasis in a recurrent breast cancer following previous axillary clearance.

BMJ case reports·2022
Same journal

Intraoperative endoscopic detection of multiple ciliary body cysts not detected preoperatively.

BMJ case reports·2026
Same journal

Can focal nodular hyperplasia transform into hepatocellular carcinoma? A 20-year journey from benign to malignant.

BMJ case reports·2026
Same journal

Isolated jejunal tuberculosis presenting as chronic intestinal obstruction.

BMJ case reports·2026
Same journal

Revision of diagnosis in a child with type 1 diabetes mellitus due to appropriate genetic testing - Wolfram Syndrome.

BMJ case reports·2026
Same journal

Bilateral corneal perforation following post-PRK fungal keratitis managed with tenons patch graft.

BMJ case reports·2026
Same journal

Early onset cerebral oedema in adult diabetic ketoacidosis with complete resolution.

BMJ case reports·2026
See all related articles

Related Experiment Video

Updated: Feb 28, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

1.8K

Thromboembolism in active ulcerative colitis.

Ian Y Goh1, Stefan Saric1, Paul Leschke2

  • 1Department of Surgery, Nambour Hospital, Nambour, Australia.

BMJ Case Reports
|June 23, 2017
PubMed
Summary
This summary is machine-generated.

Inflammatory bowel disease (IBD) patients rarely experience thromboembolism. This case highlights a young ulcerative colitis patient with multiple arterial and venous thromboses, emphasizing the need for clear treatment guidelines.

Keywords:
Inflammatory bowel diseasecrohn's diseaseulcerative colitisvascular surgeryvenous thromboembolism

More Related Videos

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

18.0K
New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
08:45

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

Published on: June 27, 2025

1.7K

Related Experiment Videos

Last Updated: Feb 28, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

1.8K
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

18.0K
New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
08:45

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

Published on: June 27, 2025

1.7K

Area of Science:

  • Gastroenterology
  • Vascular Medicine
  • Internal Medicine

Background:

  • Inflammatory bowel disease (IBD) presents with diverse intestinal and extraintestinal symptoms.
  • Thromboembolism, affecting arterial or venous systems, is an uncommon complication in IBD patients.

Observation:

  • A young patient diagnosed with ulcerative colitis presented with a rare occurrence of multiple arterial and venous thrombotic events.
  • These thrombotic events manifested across various sites within a short timeframe.
  • The patient's clinical course underscores the potential for rapid and widespread thromboembolic complications in IBD.

Findings:

  • The case demonstrates a significant association between ulcerative colitis and extensive thromboembolism.
  • Multiple thrombotic events, both arterial and venous, occurred sequentially in a young IBD patient.
  • This presentation suggests a heightened risk and potential severity of thrombotic complications in specific IBD cases.

Implications:

  • Early identification and prompt treatment of thrombosis are vital to prevent disease progression and reduce complications in IBD.
  • The case emphasizes the need for further research into the underlying mechanisms of thrombosis in IBD.
  • Development of evidence-based guidelines for thrombosis management and prophylaxis in IBD patients is urgently required.